- Report
- June 2024
Global
From €4364EUR$4,950USD£3,833GBP
- Report
- June 2023
- 65 Pages
Global
From €4364EUR$4,950USD£3,833GBP
- Report
- June 2024
- 68 Pages
Europe
From €2601EUR$2,950USD£2,284GBP
- Report
- September 2024
- 140 Pages
Asia Pacific
From €4188EUR$4,750USD£3,678GBP
- Report
- July 2024
- 208 Pages
Global
From €5290EUR$6,000USD£4,646GBP
- Report
- July 2024
- 120 Pages
Global
From €4188EUR$4,750USD£3,678GBP
- Report
- July 2024
- 130 Pages
Global
From €4188EUR$4,750USD£3,678GBP
- Report
- February 2024
- 179 Pages
Global
From €4188EUR$4,750USD£3,678GBP
- Report
- February 2024
- 120 Pages
Global
From €4188EUR$4,750USD£3,678GBP
- Report
- February 2024
- 180 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- November 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,981GBP
€4276EUR$4,850USD£3,756GBP
- Report
- November 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,981GBP
€4276EUR$4,850USD£3,756GBP
- Report
- April 2023
- 150 Pages
Global
From €3394EUR$3,850USD£2,981GBP
€4276EUR$4,850USD£3,756GBP
- Report
- June 2025
- 250 Pages
India
From €2459EUR$2,789USD£2,160GBP
- Report
- December 2024
- 150 Pages
Global
From €2960EUR$3,358USD£2,600GBP
€3482EUR$3,950USD£3,059GBP
- Report
- December 2024
- 150 Pages
Global
From €2960EUR$3,358USD£2,600GBP
€3482EUR$3,950USD£3,059GBP
- Report
- October 2024
- 70 Pages
North America
From €838EUR$950USD£736GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €838EUR$950USD£736GBP
- Report
- October 2024
- 70 Pages
Latin America
From €838EUR$950USD£736GBP
- Report
- October 2024
- 70 Pages
China
From €838EUR$950USD£736GBP

The Bio CMO market is a subset of the biopharmaceutical industry, which focuses on the production of biopharmaceuticals. Bio CMOs provide contract manufacturing services to biopharmaceutical companies, such as drug development, clinical trial materials, and commercial production. These services are typically tailored to the specific needs of the customer, and can include process development, analytical services, and quality control. Bio CMOs are also responsible for the production of biopharmaceuticals, including the manufacture of active pharmaceutical ingredients (APIs) and the formulation of finished dosage forms.
Bio CMOs are an important part of the biopharmaceutical industry, as they provide the necessary services to enable the development and production of biopharmaceuticals. Examples of companies in the Bio CMO market include Lonza, Boehringer Ingelheim, Catalent, and Patheon. Show Less Read more